Neutralizing antibodies in mucosal secretions: IgG or IgA?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current HIV Research

• Publication date

  2007-10-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016207782418452PMID 18045115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants.

  2006cited by this paper
• HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia

  2006cited by this paper
• Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.

  2006cited by this paper
• Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids

  2006cited by this paper
• Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.

  2006cited by this paper
• Immunologic Uniqueness of the Genital Tract: Challenge for Vaccine Development

  2005cited by this paper
• Human Male Genital Tract Secretions: Both Mucosal and Systemic Immune Compartments Contribute to the Humoral Immunity1

  2005cited by this paper
• Potent Neutralizing Serum Immunoglobulin A (IgA) in Human Immunodeficiency Virus Type 2-Exposed IgG-Seronegative Individuals

  2004cited by this paper
• Antiviral activity of lactoferrin towards naked viruses

  2004cited by this paper
• Presence of HIV-1 Neutralizing IgA Antibodies in Primary HIV-1 Infected Patients

  2004cited by this paper
• The antimicrobial activity of lactoferrin: Current status and perspectives

  2004cited by this paper
• Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-Type 1-Infected Individuals

  2004cited by this paper
• Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men

  2003cited by this paper
• Binding and Neutralization Activity of Human IgG1 and IgG3 from Serum of HIV-Infected Individuals

  2003cited by this paper
• ANTI-HIV AND -SIV IMMUNITY IN THE VAGINA

  2003cited by this paper
• Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals

  2002cited by this paper
• Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

  2002cited by this paper
• Human immunodeficiency virus type 2.

  2002cited by this paper
• Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.

  2002cited by this paper
• Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques

  2002cited by this paper
• Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

  2002cited by this paper
• Immunoglobulin G3 from Polyclonal Human Immunodeficiency Virus (HIV) Immune Globulin Is More Potent than Other Subclasses in Neutralizing HIV Type 1

  2001cited by this paper
• Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.

  2001cited by this paper
• HIV-Specific IgG in Cervicovaginal Secretions of Exposed HIV-Uninfected Female Sexual Partners of HIV-Infected Men

  2001cited by this paper
• Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

  2001cited by this paper
• Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection.

  2001cited by this paper
• Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia

  2000cited by this paper
• Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

  2000cited by this paper
• Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

  2000cited by this paper
• HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.

  2000cited by this paper
• Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.

  2000cited by this paper
• False Positivity of Enzyme-Linked Immunosorbent Assay for Measurement of Secretory IgA Antibodies Directed at HIV Type 1 Antigens

  2000cited by this paper
• Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody.

  2000cited by this paper
• Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity

  2000cited by this paper
• Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism.

  2000cited by this paper
• Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.

  2000cited by this paper
• Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.

  2000cited by this paper
• Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells1

  2000cited by this paper
• IgG Subclass Distribution in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects

  2000cited by this paper
• HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.

  1999cited by this paper
• Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects

  1999cited by this paper
• Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys

  1999cited by this paper
• Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

  1999cited by this paper
• Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.

  1999cited by this paper
• Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.

  1999cited by this paper
• Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.

  1999cited by this paper
• Urine antibody tests: new insights into the dynamics of HIV-1 infection.

  1999cited by this paper
• Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin.

  1999cited by this paper
• Compartmentalization of the IgG immune response to HIV-1 in breast milk.

  1999cited by this paper
• Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.

  1999cited by this paper
• Secretory Immunity in HIV Infection

  1998cited by this paper
• Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.

  1998cited by this paper
• Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells

  1998cited by this paper
• Concise Review: The Anti-HIV-1 Activity Associated with Saliva

  1997cited by this paper
• Mucosal immunity in the female genital tract.

  1997cited by this paper
• Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV‐1 infection

  1997cited by this paper
• Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.

  1997cited by this paper
• HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

  1997cited by this paper
• Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.

  1997cited by this paper
• Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women.

  1997cited by this paper
• Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.

  1997cited by this paper
• Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity

  1996cited by this paper
• Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation

  1996cited by this paper
• Cervicovaginal Anti-HIV Antibodies in Index Women from HIV-Discordant, Exclusively Heterosexual, Couples

  1996cited by this paper
• The Activity of Candidate Virucidal Agents, Low pH and Genital Secretions against HIV-1 In Vitro

  1995cited by this paper
• Decreased IgA-producing cells in the gut of SIV-infected rhesus monkeys.

  1995cited by this paper
• Normal Uterine Cervix: Characterization of Isolated Lymphocyte Phenotypes and Immunoglobulin Secretion

  1995cited by this paper
• Local Synthesis of IgG Antibodies to HIV within the Female and Male Genital Tracts during Asymptomatic and Pre-AIDS Stages of HIV Infection

  1995cited by this paper
• Nonclassical mucosal antibodies predominate in genital secretions of HIV‐1 infected chimpanzees

  1995cited by this paper
• Human immunodeficiency virus type 1 p24 antigen in cervicovaginal secretions.

  1995cited by this paper
• Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

  1995cited by this paper
• Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.

  1995cited by this paper
• Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro.

  1995cited by this paper
• Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method.

  1994cited by this paper
• Enhanced chemiluminescence as a means of increasing the sensitivity of western blot assays for HIV antibody.

  1994cited by this paper
• Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.

  1994cited by this paper
• HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.

  1994cited by this paper
• Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine

  1993cited by this paper
• Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.

  1993cited by this paper
• Characteristics of IgA Antibodies Against HIV‐1 in Sera and Saliva from HIV‐Seropositive Individuals in Different Clinical Stages

  1993cited by this paper
• Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.

  1993cited by this paper
• Infection with the Human Immunodeficiency Virus Type 2

  1993cited by this paper
• Infective and anti-infective properties of breastmilk from HIV-1-infected women.

  1993cited by this paper
• HIV-1 antibody serum negativity with urine positivity.

  1993cited by this paper
• Prevention of HIV Infection by Passive Immunization with HIV Immunoglobulin

  1991cited by this paper
• Detection of anti-HIV IgA in tears of children born to seropositive mothers is highly specific.

  1990cited by this paper
• Antibodies to human immunodeficiency virus in the breast milk of healthy, seropositive women.

  1990cited by this paper
• HIV-specific IgA antibodies in tears of children with AIDS or at risk of AIDS.

  1990cited by this paper
• Antibodies to human immunodeficiency virus in the semen of heterosexual men.

  1989cited by this paper
• Antibodies to HIV2 in genital secretions.

  1989cited by this paper
• Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women.

  1989cited by this paper
• IgG antibodies to HIV-1 in urine of HIV-1 seropositive individuals.

  1988cited by this paper
• Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component‐containing cells

  1988cited by this paper
• Components of saliva inactivate human immunodeficiency virus.

  1986cited by this paper
• Role of salivary mucins in the protection of the oral cavity.

  1982cited by this paper

• Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19

  2023cites this paper
• Research progress in the development of natural-product-based mucosal vaccine adjuvants

  2023cites this paper
• Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities

  2022cites this paper
• Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women

  2021cites this paper
• The biophysical principles underpinning muco-trapping functions of antibodies

  2021cites this paper
• The Importance of Regulation in Natural Immunity to HIV

  2021cites this paper
• Deciphering the role of mucosal immune responses and cervicovaginal microbiome in resistance to HIV infection in HIV-exposed seronegative (HESN) women

  2021cites this paper
• Induction of mucosal immunity against pathogens by using recombinant baculoviral vectors: Mechanisms, advantages, and limitations

  2020cites this paper
• Protective Activities of Mucosal Antibodies

  2020cites this paper
• Evaluation of Mucosal Humoral and Cellular Immune Responses to HIV in External Secretions and Mucosal Tissues.

  2019cites this paper
• Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract

  2019cites this paper
• Nanomedicine in the development of anti-HIV microbicides.

  2016cites this paper
• Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women

  2016cites this paper
• Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A

  2015cites this paper
• Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models

  2014cites this paper
• Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection

  2014cites this paper
• Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy

  2014influential citation
• Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection

  2014cites this paper
• Mucosal Correlates of Protection in HIV‐1‐Exposed Sero‐negative Persons

  2014cites this paper
• Recent progress in HIV vaccines inducing mucosal immune responses

  2014cites this paper
• Humoral Immune Responses to HIV in the Mucosal Secretions and Sera of HIV‐Infected Women

  2014cites this paper
• Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda.

  2014cites this paper
• Vaccination studies with the mper of HIV-1 gp41 grafted into transmembrane protein of a gammaretrovirus

  2013cites this paper
• Adaptive HIV-Specific B Cell-Derived Humoral Immune Defenses of the Intestinal Mucosa in Children Exposed to HIV via Breast-Feeding

  2013cites this paper
• Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

  2013cites this paper
• Impact of IgA Constant Domain on HIV-1 Neutralizing Function of Monoclonal Antibody F425A1g8

  2013cites this paper
• B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1.

  2012cites this paper
• Antibody Neutralizing Function of Monoclonal Impact of IgA Constant Domain on HIV-1

  2012cites this paper
• Mucosal immunoglobulin A in HIV-exposed seronegative individuals.

  2012cites this paper
• Targeting gp41 as a strategy to induce mucosal and humoral immunity against HIV-1

  2012cites this paper
• Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women

  2012influential citation
• Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection

  2011cites this paper
• Molecular characterization of the cervical and systemic B-cell repertoire

  2011cites this paper
• Mucosal Immunity in Sexually Transmitted Infections

  2011cites this paper
• CD4+ T‐cell immunity in the female genital tract is critically dependent on local mucosal immunization

  2011cites this paper
• Immune Responses to HIV in the Female Reproductive Tract, Immunologic Parallels with the Gastrointestinal Tract, and Research Implications

  2011cites this paper
• Methods for Evaluation of Humoral Immune Responses in Human Genital Tract Secretions

  2011cites this paper
• Setting of Methods for Analysis of Mucosal Antibodies in Seminal and Vaginal Fluids of HIV Seropositive Subjects from Cambodian and Italian Cohorts

  2010cites this paper
• Assessment of mucosal immunity to HIV-1

  2010cites this paper
• Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

  2010cites this paper
• The Development of an AIDS Mucosal Vaccine

  2010cites this paper
• Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies

  2010cites this paper
• HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention

  2010cites this paper
• Title The development of an AIDS mucosal vaccine

  2010cites this paper
• Scarcity or Absence of Humoral Immune Responses in the Plasma and Cervicovaginal Lavage Fluids of Heavily HIV-1-Exposed But Persistently Seronegative Women

  2010cites this paper
• Mucosal and systemic immune responses in HIV-1 exposed uninfected individuals

  2009cites this paper
• Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection.

  2009cites this paper
• An African perspective on mucosal immunity and HIV-1

  2009cites this paper
• Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors

  2009cites this paper
• HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis

  2009cites this paper
• Genital and oral mucosal immune response against HIV-1 in exposed uninfected individuals.

  2009cites this paper
• Mucosa and vaccine-induced immune protection in nonhuman primates

  2008cites this paper
• Evaluation of new strategies to elicit neutralizing antibodies against HIV-1

  2008cites this paper
• EVALUATION OF NEW STRATEGIES TO STIMULATE NEUTRALIZING ANTIBODIES AGAINST HIV-1

  2008cites this paper
• Antibody neutralization.

  2007cites this paper